Seizing the Surge: Innovations and Industrial Trends in Minimally Invasive Surgery
As a cornerstone of the entire medical device industry, minimally invasive surgery is powerfully driving surgical technology toward greater precision and intelligence by minimizing incisions, alleviating patient pain, and accelerating recovery. It plays an irreplaceable role in advancing technological progress, expanding market capacity, and fostering industrial synergy within the global medical device market.
To help unlock greater value and facilitate more transactions for high-quality innovative assets in China’s minimally invasive surgical device sector,VCBeat will be on May 10At the 2025 VBEF Top 100 Future Healthcare and Pharma Exhibition (VBEF) held at the Suzhou International Expo Center,“Forum on Innovation and Development in the Minimally Invasive Surgery Industry” held concurrently, inviting guests from China’s minimally invasive surgery enterprises and frontline investors to attend the conference and jointly promote the development of the minimally invasive surgery industry.
"Find 'Whole Industry Chain' Assets for Medical Devices, at VCBeat VBEF"
Leading Experts from Industry, Academia, Research, Healthcare, and Investment Preside; Direct Interaction of “Technology-Capital-Market” Resources
Liao Hong'en, Tenured Professor at Tsinghua UniversityOn-site sharing of technological innovation trends in integrated intelligent minimally invasive diagnosis and treatment;
Industry side,Yilu Kuaijian, Paiter, Kangji Medical, Aoruiji Medical, Gerui Technology, Ruidi BioSuccessive speeches covered hot topics such as precision medicine in minimally invasive surgery, the rise of domestic products, innovation in new materials, AI empowerment, and intelligent upgrades. Drawing on their own practices, the speakers enhanced the depth of these topics through a “perspective + case study” approach.
In addition, there areMedtronic’s Orthopedics & Neurosurgery and Surgical Businesses in China, Esun Medical, Deneng Medical, Jianxin MedicalThis article will share the challenges and opportunities in the minimally invasive surgery industry from the perspectives of multinational corporations, domestic medical device companies, and medical device CROs.
Industrial Chain + Supply Chain: Driving Efficient Collaboration Among Minimally Invasive Surgery Stakeholders
To foster in-depth exchange and collaboration among all stakeholders in the minimally invasive surgery industry chain and supply chain, VCBeat VBEF will concurrently host a series of N+ activities, including government-enterprise closed-door meetings, premium asset promotion sessions, and innovative product launch events., by adopting the integrated model of “exhibition + forum + transaction,” we facilitate deep connections between high-quality assets and global capital, local industrial chains, and end-user medical institutions, thereby helping China’s innovative healthcare and pharmaceutical assets make the leap from “innovation capability” to “productivity.”
The Exhibition Facilitates Diverse Matchmaking:2025 VBEF Special Exhibition Area DesignCenter Stage (Themed Roadshows, Product Launches), Innovative Product Showcase (Product Demonstrations, Case Studies)、Innovative Assets Poster Exhibition (TOP 100 Investment Landscape, Resource Matchmaking)Three Major Value Domains: Accelerating the Value Fission of High-Quality Assets in China’s Medical and Pharmaceutical Innovation Through Innovative Models and Efficient Mechanisms.
Forum Decoding Trends:2 Main Forums, 4 Featured Forums, and 20+ Thematic Forums comprehensively cover the hottest sectors of high-quality innovative assets in China’s healthcare and pharmaceutical industries. Over 300 industry leaders, academicians, experts, and corporate executives discuss growth poles in China’s healthcare industry, precisely identifying growth drivers for high-quality assets.
High-Efficiency Transaction Scenarios:Exhibiting companies can engage directly with international buyers, overseas distributors, and supply chain partners. Through on-site negotiations and demand-matching sessions, they can quickly secure business opportunities in cross-border cooperation, technology introduction, and product distribution, thereby facilitating the integration of China’s high-quality innovative medical and pharmaceutical assets into the global industrial chain.
Registration Open to Industry Partners, and engage in direct communication and cooperation negotiations with innovative enterprises.
Claim your free tickets—limited quantity, first come, first served!
Share this article/poster to your WeChat Moments and collect 18 likes,
Add the Organizing Committee (Note: Ticket Benefits),
Get one ticket worth RMB 399 (excluding meals)!
Ms. Jing, Organizing Committee
Exhibition Name:2025 VBEF Future Healthcare & Medicine Top 100 Expo
Exhibition Dates:May 9–10, 2025
Venue:China · Suzhou · International Expo Center
Exhibition Scale:16,000+ patient visits
(More partners to be confirmed. Stay tuned to VBEF for the latest updates.)
Organizer:VCBeat
Co-organized by:Artery New Medicine, ATLATL Innovation Center, Enshe Family Office, Dr. Fang, Guoke Hengtai, He Eye Hospital, Health Growth Society, JD Health, Niukou Capital, Panlin Capital, Probe Capital, Vostech, Meet the Future, Eye Valley Select, China Eye Valley
Forum Supporting Organizations:MathWorks, Pivotal bioVenture, Akang Cloud Medicine, Amet Medical, Aibu Technology, Aurigene, Aurigene Medical, Bailun Technology, Basefly, Biovalve·Changdi, Bose Quantum, Bohe Innovation Center, DAMO Academy, Deneng Medicine, Desheng Biology, Dipu Shenhe, Dingfeng Capital, Dongmai Medical, Fanzhuo Group, Fuwo Pharma, Fuxin Sci-Tech Innovation, Ganwei, Gerui Technology, Haihu Health, Haimosi Biology, Hengxu Capital, Hunan Provincial Medical Device Industrial Park, Huamei Haolian, Huixin Health, Huimei Digital Technology, Jiamuyao, Health Road, Jieshi Medical, Jinghan Medical Materials, Lejian Health, Lide Health, Lianren Health, Legend Star, Linsheng Polymer, Linglan, Lulutong, Maide Intelligence, Owl Biology, Maijian, Natray, Nanda Feite, Nuanyang Medical, Puyi Biology, Puchuang Medical, Ruisen Medical, Shanqiu Liankang, Shangyong Technology, Shanghai AllBright Law Offices, Shuimu Jinsheng, Silu Sai Biology, Suosi Medical, Taozi Health, Tonghe Litai, Topcon Medical, Weimei Health, Xiyi Medicine, Xikang Cloud Hospital, Xiezi Incubator, Xinjing Technology, Xinhong Electronics, Xiushi Biology, Yanyin Technology, Yaoyi Cloud, Yishu Health, Yi'an Medical, Yijiada, Yinlian Health, British Consulate-General, Youlin Pharma, Zhejiang Kayi, Zhenghexiang Health Pharmacy, Knowledge Matrix, Zhirui Technology, China Pharmaceutical University Suzhou Alumni Association, Zhongjiandai, Zhongrui Pharmaceutical Business School, Jones Lang LaSalle
Supported by:Proxima Ventures, Boyuan Capital, Bencao Capital, Changfa Group, Chende Capital, Changling Capital, Daotong Investment, Panlin Capital, Danlu Capital, GTJA Innovation Capital, Sequoia China, Honghui Fund, Huagai Capital, Legend Capital, Matrix Partners China, Lenovo Star, Qingsong Capital, Qiming Venture Partners, Shenzhen Capital Group, Shanghai Industrial Capital, Xianfeng Qiyun, Sunshine Ronghui Capital, Yuanhe Origin, Yuansheng Venture Capital, Yuanyi Capital
Supported Parks:Changping Life Valley Industrial Base, Optics Valley Bio-City/Wuhan Gaoke Medical Device Park, Haicheng Digital Medical Industry Park, Jiangsu Medical Device Technology Industrial Park, Shanghai Free Trade Zone No. 1 Life Science and Technology Industrial Park, Greater Bay Area Biosafety Innovation Port, Zhongguancun (Tongzhou) Innovative Medical Translation Industrial Park (Yifang Health Valley)
Exhibition Support Media:21st Century Business Herald, E-Pharma Academy, MedWorld Device World, Bioon Valley, TouchBio, Cyzone, Big Health Pie, Hao De Ya, Huihui Pharmacist, Jixiao 361, Jiankangjie (Healthcare Circle), Quick Doctor Inquiry, Bioon Valley, Device Seller, Taidu TIMEDOO, Tansi Bio, Investment Circle, Sina Medicine, Xiaofanzhuo, Information Hero, Yao Fangzhou, Yaokahui, YAOZH, Yao Peng Xie You, Medical Engineering Scholars, Yi Qianyan, The Medical World, Pharmaceutical Manager, PharmaCube, Zhiyi News